• No results found

18 results with keyword: 'comorbidities impact outcomes autologous transplant relapsed hodgkin lymphoma'

Comorbidities, Not Age, Impact Outcomes in Autologous Stem Cell Transplant for Relapsed Non-Hodgkin Lymphoma

High-dose chemotherapy followed by autologous peripheral blood stem cell transplantation is a widely applied treatment for advanced non-Hodgkin lymphoma (NHL), but few studies

Protected

N/A

7
0
0
2021
Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival

High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma:

Protected

N/A

12
0
0
2020
Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients

Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma. The role of

Protected

N/A

10
0
0
2020
Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma

Long- term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin

Protected

N/A

13
0
0
2021
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Brentuximab vedotin plus ESHAP (BRESHAP) is a highly effective combination for inducing remission in refractory and relapsed Hodgkin lymphoma patients prior to autologous stem

Protected

N/A

9
0
0
2020
Addressing Substance and Alcohol Use Prior to HCV Treatment

An Integrated Alcohol Abuse and Medical Treatment Model for Patients With HCV.. Adapted from Proeschold-Bell RJ, Patkar AA, Naggie S, Coward L, Mannelli P, Yao J, Bixby P,

Protected

N/A

26
0
0
2021
Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/ refractory aggressive B-cell non-hodgkin lymphoma

We retrospectively compared outcomes of patients with relapsed/refractory non- Hodgkin lymphoma (NHL) who underwent stem cell transplantation (SCT) with stable disease or

Protected

N/A

13
0
0
2020
Use of the financial sector for money laundering: a perspective from the Ecuadorian legislation

El presente trabajo de investigación se desarrolló con base en una revisión documental que abarca el estudio y análisis bi- bliográfico sobre la diferente normativa emitida

Protected

N/A

22
0
0
2021
Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation. Hahn T, McCarthy

Protected

N/A

13
0
0
2020
QUESTIONING HOMEOPATHY

First is "like cures like" means treatment of disease by the use of small amounts of drug that in healthy persons produce symptoms similar to those of the disease

Protected

N/A

12
0
0
2020
New-Onset Lymphopenia Assessed during Routine Follow-up Is a Risk Factor for Relapse Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Diffuse Large B-Cell Lymphoma

Risk factors used to assess clinical outcomes in non-Hodgkin lymphoma (NHL) patients treated with autologous peripheral blood hematopoietic stem cell transplantation (APHSCT)

Protected

N/A

8
0
0
2021
'What skills do i have? What skills will i need?' Building an employability skills profile through an online reflective learning program

The purpose of this research is to describe a proposed design for an innovative multidisciplinary online program for Work Integrated Learning [WIL], which facilitates and guides

Protected

N/A

18
0
0
2019
PubMedCentral-PMC5665725.pdf

We describe the outcomes of 253 patients with relapsed WT who received high-dose chemotherapy (HDT) followed by autologous hematopoietic stem cell transplant (HCT) between 1990

Protected

N/A

16
0
0
2020
Community Safety The Environment Current Management Practices

Outlined here are the estimated shot fall zones for the Club’s trap shooting (green) and skeet shooting (red) fields... The wetlands north of the range

Protected

N/A

44
0
0
2022
ARKANSAS STATE BOARD OF PHYSICAL THERAPY RULES AND REGULATIONS

The examination for the physical therapist or physical thera- pist assistant shall be the appropriate level examination pro- cured from the an examination service

Protected

N/A

10
0
0
2021
Space for: supply and demand HARCOURT BUSINESS PARK BOTANY ROAD, ROSEBERY, NSW

Positioned on the corners of Botany Road, Harcourt Parade and Dunning Avenue in Rosebery, the estate is located within close proximity to Sydney Airport, Port Botany and

Protected

N/A

13
0
0
2022
CHAPTER 10: GROWTH LEARNING OUTCOMES: 10.1 Measurement of Growth a) Define growth b) Explain how growth is measured.

Which of the following growth curve best represents growth in insect, birds and human.. Intermitten

Protected

N/A

6
0
0
2021

Upload more documents and download any material studies right away!